Stocks
Cara Therapeutics (CARA) ROA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| ROA, % | ? | -35.7% | -45.8% | -94.2% | -161.7% | -56.8% | -77.9% | ||
| Changes by years, y/y, % | -39pp | -10pp | -48pp | -68pp | +105pp | -79% | |||
Cara Therapeutics. ROA, %
Cara Therapeutics. ROA, changes, pp
Cara Therapeutics (CARA) ROA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| ROA, % | ? | -47.8% | -35.7% | -62.7% | -77.9% | -175.5% | -77.9% | |
| Changes by years, y/y, % | +105pp | +150pp | +99pp | +38pp | -128pp | |||
| Changes by quarters, q/q, % | +68pp | +12pp | -27pp | -15pp | -98pp | |||
